ScionxBio announces collaboration to develop long-acting xRNA therapeutics

ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA therapeutics, distinguished by their extended…

Continue ReadingScionxBio announces collaboration to develop long-acting xRNA therapeutics

Takara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies

Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., and SPT Labtech today announced their partnership to deliver validated, automated library preparation workflows that combine Takara Bio…

Continue ReadingTakara Bio USA partners with SPT Labtech to deliver automation-ready NGS library preparation technologies